Haemodialysis

Minimising your patients’ risks for cardiovascular morbidity and mortality

Despite significant improvements in the quality and efficacy of haemodialysis therapy in recent years, Cardiovascular Disease (CVD) remains the leading cause of death for dialysis patients. Today, almost every other dialysis patient dies from cardiovascular complications. Fresenius Medical Care supports nephrologists worldwide in minimising their patients’ risks for cardiovascular morbidity and mortality.

Fresenius Medical Care continuously strives to develop and implement innovative therapies and products to improve the cardiovascular prognosis of dialysis patients.